Neuroinflammation in CNS Disorders
From Bench to Bedside: Advances in Neuroinflammation and CNS Disorder Research
Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Neuroinflammation in CNS Disorders
Handling Editor
Prof. Masaru Tanaka (University of Szeged, Department of Neurology; Hungarian Academy of Sciences, Hungary; ORCID 0000-0002-0067-6073) tanaka.masaru.1@med.u-szeged.hu
The editors of this special collection invite submissions exploring the latest advances in clinical and experimental research on neuroinflammation in the central nervous system (CNS). Neuroinflammation is at the forefront of neuroscience, shaping our understanding of CNS disorders such as neurodegenerative disease, psychiatric disorders, and traumatic brain injuries. This collection aims to unite diverse perspectives, fostering insights into the complex cellular and molecular mechanisms driving neuroinflammatory processes. We encourage the submission of original research, meta-analyses, and comprehensive review articles that shed light on diagnostic, therapeutic, and mechanistic aspects of CNS inflammation.
We are particularly interested in manuscripts that explore the interplay between immune cells, neurons, and glia, with a focus on translational research. Contributions detailing innovative diagnostic approaches, therapeutic targets, or computational models are highly welcome. Join this effort to advance the boundaries of neuroinflammation research and contribute to groundbreaking findings that bridge laboratory and clinical neuroscience.
Advances in Clinical and Experimental Medicine is therefore seeking original papers for a Special Collection focused on the following themes:
- neuroimmune interactions in health and disease
- cellular and molecular pathways of neuroinflammation
- neuroinflammation and neurodegeneration: cause or consequence?
- innovative imaging and biomarkers for CNS inflammation
- therapeutic interventions targeting neuroinflammation
- role of microglia and astrocytes in neuroinflammatory diseases
Submission process
As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med managing editor: to the managing editor [marek.misiak@umw.edu.pl].
The Section Editor jointly with the Editor-in-Chief will review all submissions and select those which will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.
Dates and fees
- Submission of Expression of Interest until December 31, 2025, to the ACEM managing editor [marek.misiak@umw.edu.pl];
- Invitation to submit full paper by February 28, 2026;
- Submission of full paper by June 30, 2026.
If accepted, Authors will be required to pay a fee (https://advances.umw.edu.pl/en/article-processing-charges/) to cover publication costs. For selected Authors (outstanding experts), it is possible to reduce or even cancel the publication fee.
We eagerly anticipate a diverse and truly global collection of papers and insights, driving scientific discovery and innovation to new heights on the world stage!